GERN
GERON CORP
NASDAQ · Healthcare · Biotechnology · US
$1.20
+2.56%Forward multiples
Based on analyst estimates
- P/E forward
- 25.03x
- P/E 2026E
- —
- P/E 2027E
- 16.22x
- P/E 2028E
- 4.80x
- P/S forward
- 2.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.53x
- Price / sales
- 3.77x
- Price / cash flow
- -6.74x
Enterprise value
- Enterprise value
- $592.3M
- EV / sales
- 2.90x
- EV / EBITDA
- -14.32x
- EV / EBIT
- -15.83x
- Market cap
- $771.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026